Zhejiang Hisun Pharmaceutical Co., Ltd. provided earnings guidance for the first half of 2019. For the period the company predicts the net profit belonging to shareholders of the listed company from January to June in 2019 will be between RMB 48 million and RMB 57 million, with an increase of between RMB 33.16 million and RMB 42.16 million compared with the same period of 2018 and with a year-on-year increase of between 223% and 284%. The net profit belonging after excluding extraordinary profit and loss from January to June in 2019 will be between RMB 1 million and RMB 8 million, with an increase of between RMB 63.63 million and RMB 70.63 million compared with the same period of 2018.